Quynh Anh Bui

Ms. Quynh Anh Bui

Institute of Applied Materials Science, Vietnam Academy of Science and Technology
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
TNThe Ngoc Nguyen
The Ngoc Nguyen
DNDinh Trung Nguyen
Dinh Trung Nguyen
Quynh Anh BuiQuynh Anh Bui
Quynh Anh Bui
PHPhuong Duy Huynh
Phuong Duy Huynh
QNQuang Huy Nguyen
Quang Huy Nguyen
NVNguyen Thanh Viet
Nguyen Thanh Viet
Introduction: Multi-drug nanosystem has been employed in several therapeutic models due to the synergistic effect of the drugs and/or bioactive compounds, which help in tumor targeting and limit the usual side effects of chemotherapy. Methods: In this research, we developed the amphiphilic Heparin-poloxamer P403 (HSP) nanogel that could load curcumin (CUR) and Paclitaxel (PTX) through the hydrophobic core of Poloxamer P403. The features of HSP nanogel were assessed through Fourier-transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM), differential light scattering (DLS), and critical micelle concentration (CMC). Nanogel and its dual drug-loaded platform showed high stability and spherical morphology. Results: The drug release profile indicated fast release at pH 5.5, suggesting effective drug distribution at the tumor site. In vitro research confirms lower cytotoxicity of HSP@CUR@PTX compared to free PTX and higher inhibition effect with MCF-7 than HSP@PTX. These results support the synergism between PTX and CUR. Conclusion,: HSP@CUR@PTX suggests a prominent strategy for achieving the synergistic effect of PTX and CUR to circumvent undesirable effects in breast cancer treatment.

14 January 2022 in Gels
Verified
Journal Article
Open access
PDF file
TNThe Ngoc Nguyen
The Ngoc Nguyen
Quynh Anh BuiQuynh Anh Bui
Quynh Anh Bui
HNHoang Huong Nhu Nguyen
Hoang Huong Nhu Nguyen
Tien Thanh NguyenTien Thanh Nguyen
Tien Thanh Nguyen
KLKhanh Linh Ly
Khanh Linh Ly
TNTrung Nguyen
Trung Nguyen
Nanosized multi-drug delivery systems provide synergistic effects between drugs and bioactive compounds, resulting in increased overall efficiency and restricted side effects compared to conventional single-drug chemotherapy. In this study, we develop an amphiphilic heparin-poloxamer P403 (HP403) nanogel that could effectively co-load curcuminoid (Cur) and cisplatin hydrate (CisOH) (HP403@CisOH@Cur) via two loading mechanisms. The HP403 nanogels and HP403@CisOH@Cur nanogels were closely analyzed with 1H-NMR spectroscopy, FT-IR spectroscopy, TEM, and DLS, exhibiting high stability in spherical forms. In drug release profiles, accelerated behavior of Cur and CisOH at pH 5.5 compared with neutral pH was observed, suggesting effective delivery of the compounds in tumor sites. In vitro studies showed high antitumor activity of HP403@CisOH@Cur nanogels, while in vivo assays showed that the dual-drug platform prolonged the survival time of mice and prevented tail necrosis. In summary, HP403@CisOH@Cur offers an intriguing strategy to achieve the cisplatin and curcumin synergistic effect in a well-designed delivery platform that increases antitumor effectiveness and overcomes undesired consequences caused by cisplatin in breast cancer treatment.